NCT00224302View on ClinicalTrials.gov

Treatment of MDEs During the Course of Psychotic Disorders With Duloxetine

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions
Psychotic Disorders
Interventions
DRUG

Duloxetine

Trial Locations (1)

68159

Central Institute of Mental Health, Department of Psychiatry,, Mannheim

All Listed Sponsors
lead

Central Institute of Mental Health, Mannheim

OTHER

NCT00224302 - Treatment of MDEs During the Course of Psychotic Disorders With Duloxetine | Biotech Hunter | Biotech Hunter